EP300-PAICS Fusion FISH Probe
The EP300-PAICS Fusion FISH Probe is used to confirm a fusion of the EP300 and PAICS genes. The fusion of the EP300 and PAICS genes has been associated with Uterine Corpus Endometrial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| EP300-PAICS-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| EP300-PAICS-20-RERE | 20 (40 μL) | 200 μL |
|
|
| EP300-PAICS-20-REOR | 20 (40 μL) | 200 μL |
|
|
| EP300-PAICS-20-REGO | 20 (40 μL) | 200 μL |
|
|
| EP300-PAICS-20-REGR | 20 (40 μL) | 200 μL |
|
|
| EP300-PAICS-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| EP300-PAICS-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| EP300-PAICS-20-OROR | 20 (40 μL) | 200 μL |
|
|
| EP300-PAICS-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| EP300-PAICS-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| EP300-PAICS-20-GORE | 20 (40 μL) | 200 μL |
|
|
| EP300-PAICS-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| EP300-PAICS-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| EP300-PAICS-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| EP300-PAICS-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| EP300-PAICS-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| EP300-PAICS-20-GROR | 20 (40 μL) | 200 μL |
|
|
| EP300-PAICS-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| EP300-PAICS-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| EP300-PAICS-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| EP300-PAICS-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| EP300-PAICS-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| EP300-PAICS-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| EP300-PAICS-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| EP300-PAICS-20-AQAQ | 20 (40 μL) | 200 μL |
|
EP300 Gene Summary
This gene encodes the adenovirus E1A-associated cellular p300 transcriptional co-activator protein. It functions as histone acetyltransferase that regulates transcription via chromatin remodeling and is important in the processes of cell proliferation and differentiation. It mediates cAMP-gene regulation by binding specifically to phosphorylated CREB protein. This gene has also been identified as a co-activator of HIF1A (hypoxia-inducible factor 1 alpha), and thus plays a role in the stimulation of hypoxia-induced genes such as VEGF. Defects in this gene are a cause of Rubinstein-Taybi syndrome and may also play a role in epithelial cancer. [provided by RefSeq, Jul 2008]
Gene Name: E1A Binding Protein P300
Chromosome: CHR22: 41488613 -41576081
Locus: 22q13.2
PAICS Gene Summary
This gene encodes a bifunctional enzyme containing phosphoribosylaminoimidazole carboxylase activity in its N-terminal region and phosphoribosylaminoimidazole succinocarboxamide synthetase in its C-terminal region. It catalyzes steps 6 and 7 of purine biosynthesis. The gene is closely linked and divergently transcribed with a locus that encodes an enzyme in the same pathway, and transcription of the two genes is coordinately regulated. The human genome contains several pseudogenes of this gene. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Gene Name: Phosphoribosylaminoimidazole Carboxylase And Phosphoribosylaminoimidazolesuccinocarboxamide Synthase
Chromosome: CHR4: 57301914 -57327534
Locus: 4q12
Gene Diseases
The EP300 PAICS Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Uterine Corpus Endometrial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|